1. Home
  2. SCYX vs CISO Comparison

SCYX vs CISO Comparison

Compare SCYX & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • CISO
  • Stock Information
  • Founded
  • SCYX 1999
  • CISO 2015
  • Country
  • SCYX United States
  • CISO United States
  • Employees
  • SCYX N/A
  • CISO N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • SCYX Health Care
  • CISO Technology
  • Exchange
  • SCYX Nasdaq
  • CISO Nasdaq
  • Market Cap
  • SCYX 28.5M
  • CISO 31.4M
  • IPO Year
  • SCYX 2014
  • CISO N/A
  • Fundamental
  • Price
  • SCYX $0.70
  • CISO $1.09
  • Analyst Decision
  • SCYX
  • CISO
  • Analyst Count
  • SCYX 0
  • CISO 0
  • Target Price
  • SCYX N/A
  • CISO N/A
  • AVG Volume (30 Days)
  • SCYX 138.2K
  • CISO 909.3K
  • Earning Date
  • SCYX 08-07-2025
  • CISO 08-13-2025
  • Dividend Yield
  • SCYX N/A
  • CISO N/A
  • EPS Growth
  • SCYX N/A
  • CISO N/A
  • EPS
  • SCYX N/A
  • CISO N/A
  • Revenue
  • SCYX $2,630,000.00
  • CISO $29,887,603.00
  • Revenue This Year
  • SCYX $463.61
  • CISO N/A
  • Revenue Next Year
  • SCYX $310.80
  • CISO N/A
  • P/E Ratio
  • SCYX N/A
  • CISO N/A
  • Revenue Growth
  • SCYX N/A
  • CISO N/A
  • 52 Week Low
  • SCYX $0.66
  • CISO $0.26
  • 52 Week High
  • SCYX $2.29
  • CISO $3.84
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 38.69
  • CISO 46.11
  • Support Level
  • SCYX $0.67
  • CISO $1.16
  • Resistance Level
  • SCYX $0.75
  • CISO $1.24
  • Average True Range (ATR)
  • SCYX 0.04
  • CISO 0.10
  • MACD
  • SCYX 0.00
  • CISO -0.02
  • Stochastic Oscillator
  • SCYX 33.06
  • CISO 6.06

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: